May 7th, 2012
•Here we describe the first good manufacturing practice (GMP)-compliant method of producing virus-specific cytotoxic T lymphocytes (CTL) from umbilical cord blood, a source of predominantly naîve T cells.
Verwandte Videos
Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Introducing Shear Stress in the Study of Bacterial Adhesion
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Generation of Human Alloantigen-specific T Cells from Peripheral Blood
Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten